Evidence map›Paper›PMID 17084817›Full record

ArticleBiochemical and biophysical research communications2006

Reciprocal keratin 18 Ser48 O-GlcNAcylation and Ser52 phosphorylation using peptide analysis.

Guo-Zhong Tao, Celeste Kirby, Stephen A Whelan, Frank Rossi, Xiahui Bi, Michael MacLaren, Erik Gentalen, Roger A O'Neill, Gerald W Hart, M Bishr Omary

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. ACS central science · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Guo-Zhong TaoPalo Alto VA Medical Center, Stanford University, Palo Alto, CA 94304, USA.
Celeste Kirby
Stephen A Whelan
Frank Rossi
Xiahui Bi
Michael MacLaren
Erik Gentalen
Roger A O'Neill
Gerald W Hart
M Bishr Omary
Johns Hopkins Medicine · USStanford University · US

Funding

Regulation and Dynamics of Keratins in Digestive OrgansR01DK052951 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 1997 to 2015
$4.5M
Cytosolic O-Glycosylation and Insulin SignalingR01DK061671 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 2002 to 2014
$4.0M
GLYCOCONJUGATES IN DEVELOPMENT AND IMMUNITYR37HD013563 · NICHD · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 1998 to 2007
$3.4M
Genetic and molecular effects on hepatocyte nucleocytoplasm protein aggregationR56DK052951 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OMARY, BISHR · 2012 to 2012
$179k
PROTEOGLYCANS AND GLYCOPROTEINS OF DEVELOPING THYMUSR01HD013563 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HART, GERALD WARREN · 1985 to 1997
–
NICHD NIH HHS HD13563NICHD NIH HHS R37 HD013563NIDDK NIH HHS DK52951NIDDK NIH HHS DK61671NIDDK NIH HHS R01 DK052951NIDDK NIH HHS R01 DK061671NIDDK NIH HHS R56 DK052951
6 · The paper itself

Abstract

Phosphorylation and O-GlcNAcylation of keratin 18 (K18) are highly dynamic and involve primarily independent K18 populations. We used in vitro phosphorylation and O-GlcNAcylation of wild-type, phospho-Ser52, glyco-Ser48, and Ser-to-Ala mutant 17mer peptides (K18 amino acids 40-56), which include the major K18 glycosylation (Ser48) and phosphorylation (Ser52) sites, to address whether each modification blocks the other. The glyco-K18 peptide blocks Ser52 phosphorylation by protein kinase C, an in vivo K18 kinase, while the phospho-K18 peptide blocks its O-GlcNAcylation. Our findings support the reciprocity of these two post-translational modifications. Therefore, regulation of protein Ser/Thr phosphorylation and glycosylation at proximal sites can be interdependent and provides a potential mechanism of counter regulation.

Indexed as

AcylationAmino Acid SubstitutionGlycineKeratin-18PeptidesPhosphorylationSerineStructure-Activity RelationshipGlycineKeratin-18PeptidesSerine

Identifiers

PMID17084817
PMCPMC2692749
OpenAlexW2000467647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.